Purpose | Patients | Evaluations | Perceived Effectiveness |
---|---|---|---|
Coronary artery disease | 5 | 13 | |
Antiphospholipid antibody syndrome | 2 | 1 | |
General health | 2 | 0 | |
Migraine | 2 | 2 | |
Prevent blood clotting | 2 | 1 |
Side effect severity
Severity | Evaluations | Percentage |
---|---|---|
Severe | 0 | |
Moderate | 0 | |
Mild | 0 | |
None | 16 |